
1. j biol chem. 2012 may 11;287(20):16199-208. doi: 10.1074/jbc.m111.335216. epub
2012 mar 27.

kaposi sarcoma-associated herpesvirus virf-3 protein binds f-box skp2
protein acts regulator c-myc protein function stability.

baresova p(1), pitha pm, lubyova b.

author information: 
(1)institute immunology microbiology, first medical faculty charles
university, 12800 prague, czech republic.

the kaposi sarcoma-associated herpesvirus (kshv) linked kaposi
sarcoma, body cavity-based lymphoma, castleman disease. virf-3 kshv
latent gene critical proliferation kshv-positive lymphoid cells.
furthermore, virf-3 contributes kshv-associated pathogenesis stimulating
c-myc transcription activity. show virf-3 associate skp2, a
key component scf(skp2) ubiquitin ligase complex. skp2 a
transcriptional co-factor c-myc shown regulate stability of
c-myc protein well c-myc-dependent transcription. study, show
that virf-3 binds f-box skp2 recruits c-myc-regulated
promoters activate c-myc-dependent transcription. additionally, cells
overexpressing virf-3 exhibit higher levels c-myc ubiquitylation, suggesting
that ubiquitylation necessary c-myc-mediated transcription. moreover,
virf-3 stabilize c-myc protein increasing half-life. collectively,
these results indicate virf-3 effectively manipulate c-myc stability and
function thus contribute c-myc-induced kshv-associated lymphomagenesis.

doi: 10.1074/jbc.m111.335216 
pmcid: pmc3351320
pmid: 22453922  [indexed medline]

